A clinical trial assessing BIOKANGTAI COVID-19 Vaccine
Latest Information Update: 06 Aug 2021
At a glance
- Drugs COVID-2019 vaccine-Shenzhen Kangtai Biological Products (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 06 Aug 2021 New trial record
- 02 Aug 2021 According to Shenzhen Kangtai Biological Products media release, BIOKANGTAI has received clinical approval in Ukraine and is expected to launch this trial in early August.